NCPA Flags Job-Killing Federal Regulations for House Committee Chairman

Share |

Alexandria, Va. - June 1, 2012 Rep. Darrell Issa (R-CA), Chair of the U.S. House Committee on Oversight and Government Reform, recently contacted 200 business organizations, including the National Community Pharmacists Association (NCPA), seeking their insight on regulations that hurt job creation. NCPA responded today in a letter that focuses on three problematic policies for independent community pharmacies:

  • The Medicare Part B diabetes testing supplies competitive bidding program, the expansion of which threatens patient access to these medical necessities;
  • The 340B drug discount program, due to its loose eligibility criteria; and
  • The fee-for-service (FSS) Medicare enrollment/revalidation fees that many pharmacies have to pay twice.

NCPA's letter details "the regulatory burdens faced by independent community pharmacies," as well as "examples of rules and regulations where a federal agency did not fully and effectively comply with the rulemaking process."

NCPA's common-sense solutions offered to the committee to the aforementioned concerns were:

  • To maintain seniors' access to diabetes testing supplies, NCPA supports a permanent exemption for independent community pharmacies as proposed in H.R. 1936, the Medicare Diabetes Access to Care Act, sponsored by Reps. Aaron Schock (R-IL) and Peter Welch (D-VT);
  • To reform 340B, NCPA supports explicitly closing the language loopholes that allow the program's prescriptions to be used for patients other than the intended recipients—uninsured and underinsured Americans; and
  • To stop the double billing for Medicare Part B enrollment and revalidation, NCPA supports making sure the Centers for Medicare and Medicaid Services (CMS) is interpreting the statute as Congress intended.

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies. Together they represent a $93 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 315,000 people, including 62,400 pharmacists. Independent community pharmacists are readily accessible medication experts who can help lower health care spending. They are committed to maximizing the appropriate use of lower-cost generic drugs and reducing the estimated $290 billion that is wasted annually by improper medication use. To learn more go to or read NCPA's blog, The Dose, at

Ask Your Family Pharmacist TM